AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but the company has very little information about the case, its CEO said on ...

AstraZeneca's China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was described as cooperating "with an ongoing investigation", the ...

AstraZeneca targets $80bn revenue by 2030, ... AstraZeneca: Fascinating Company With Lofty Ambitions - Just Not A Buy Yet. Jun. 07, 2025 4:55 AM ET AstraZeneca PLC (AZN) ...

Transparent background logos will be available in the near future. The company logo API has coverage of all stocks trading on major US exchanges, major OTC listing and major fund families.

UBS analyst Matthew Weston maintained a Sell rating on AstraZeneca (AZN – Research Report) today and set a price target of £113.00. The company’s shares opened today at p12,884.00. According ...

AstraZeneca joins as the sixth pharma company, and the first non-US company, to file suit against the Biden Administration over Medicare drug pricing.

In a notice issued to the London Stock Exchange on the company’s share price movement, AstraZeneca (AZN) stated: “As a matter of policy, we do not comment on speculative media reports ...

And if a company’s goal is to use its logo to communicate boldness as a brand attribute, the single most obvious, literal, no-brainer way to do so is to just put it in bold.

The logo of the British pharmaceutical company AstraZeneca is seen at the company's China Commercial Innovation Centre (CCIC) in Wuxi, Jiangsu province, China, September 15, 2018. Picture taken ...

AstraZeneca said on Tuesday it will acquire biotech company Fusion Pharmaceuticals for up to $2.4 billion, expanding its pipeline of treatment for advanced prostate cancer.

AstraZeneca's industry-leading oncology portfolio brought in $3,701 million in Q2 2022, representing 34.8% of the company's total revenue, while their combined sales posted a 20% year-over-year ...